Products
Online Inquiry
UNBS5162
Cat. No.:
0225LY-0504
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
UNBS5162 is a naphthalimide-based compound designed to lower the expression of CXCL chemokines in experimental models of prostate cancer.
Synonym:
UNBS 5162 ;UNBS-5162; 956590-23-1; 1-(2-(2-(Dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea; [2-[2-(Dimethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]urea; Urea, N-(2-(2-(dimethylamino)ethyl)-2,3-dihydro-1,3-dioxo-1H-benz(de)isoquinolin-5-yl)-
CAS No.:
956590-23-1
Compound CID:
16048966
Formula:
C17H18N4O3
Formula Weight:
326.35
Specification
Relative Density:
1.389 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
UNBS5162 can be used in cancer biology studies to explore its role as a pan-antagonist of CXCL chemokine expression.
Library Information
Target:
CXCR
Receptor:
CXCL; CXCR
Pathways:
GPCR/G protein signaling; Immunology/Inflammation; Autophagy
Plate Number:
AOCL-7
Plate Location:
e6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
11 mg/mL; 33.71 mM
